HHS has filed a notice of appeal to challenge a federal judge's decision to block the implementation of a Trump administration rule that would have required pharmaceutical firms to disclose the prices of their products in television ads. "If the drug companies are embarrassed by their prices or afraid that the prices will scare patients away, they should lower them," HHS spokeswoman Caitlin Oakley said.
HHS moves to challenge ruling blocking drug price disclosure in TV ads
Sign up for FDLI SmartBrief
News for the food and drug law community
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.